Latest news
Loading news…
Abexxa Biologics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Arlington, Texas, United States Founded 2015 11-50 employees For Profit
Abexxa Biologics is a biopharmaceutical company that focuses on discovering and developing breakthrough antibody-based drugs.
Abexxa Biologics was acquired by Boehringer Ingelheim in 2021.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
5
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 4
- Patents granted
- 5
- Trademarks
- 0
- Top patent class
- Organic Chemistry
- IT spend
- $9M
Company Info
- Founded
- 2015
- Employees
- 11-50
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 5
- HQ
- Arlington, Texas, United States
- Region
- Dallas/Fort Worth Metroplex, Southern US
- Diversity spotlight
- Women Founded; Women Led
- Exit date
- Sep 21, 2021
Signals & Scores
- Heat score
- Low
- Trend (7d)
- 2.5
- Trend (30d)
- 0.3
- Trend (90d)
- 1.2
Key People at Abexxa Biologics
Co-Founder & Chief Scientist
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Abexxa Biologics
Loading news…
FAQs about Abexxa Biologics
People who checked this page also checked these
Browse the full Acquirezy directory.